Table 2.
Main findings at hospital admission of study participants.
| COVID-19 Patients (n = 157) | |
|---|---|
| Days of symptom onset, median (IQR) | 7.0 (4.7 to 9.0) |
| Clinical data | |
| Temperature > 37.3 °C, n (%) | 57 (36.3) |
| Respiratory rate, breaths/min | 26.0 ± 11.8 |
| Heart rate, beats/min | 96.2 ± 19.8 |
| Systolic blood pressure, mmHg | 124.7 ± 21.0 |
| Diastolic blood pressure, mmHg | 75.9 ± 13.5 |
| Oxygen saturation at room air, % | 79.5 ± 13.1 |
| Classified as severe COVID-19, n (%) | 125 (79.6) |
| Laboratory values | |
| White cell count (×103 per mm3), median (IQR) | 8.9 (6.1 to 12.3) |
| Neutrophils (×103 per mm3), median (IQR) | 7.7 (4.8 to 11.0) |
| Lymphocytes (×103 per mm3), median (IQR) | 0.8 (0.6 to 1.1) |
| Platelets (×103 per mm3), median (IQR) | 207 (164 to 275) |
| Hemoglobin, g/dL, median (IQR) | 14.7 (13.2 to 16.0) |
| Albumin, g/dL, median (IQR) | 3.4 (3.1 to 3.8) |
| Serum creatinine, mg/dL, median (IQR) | 1.0 (0.8 to 1.4) |
| Troponin I, ng/mL, median (IQR) | 12.8 (6.1 to 63.8) |
| Creatine kinase, U/L, median (IQR) | 105 (49 to 199) |
| D-dimer, ng/mL, median (IQR) | 390 (228 to 666) |
| Fibrinogen, mg/dL, median (IQR) | 5.3 (4.4 to 6.1) |
| C-reactive protein, mg/L, median (IQR) | 145 (61 to 256) |
| Ferritin, μg/L, median (IQR) | 590 (270 to 1101) |
| Interleukin 6, pg/mL, median (IQR) | 14.9 (4.5 to 73.5) |
Data are presented as mean ± standard deviation unless otherwise specified.